Kevin Mcculloch
President and Chief Operating Officer · 8 filings · Latest: Oct 1, 2026
Xeris Biopharma Holdings, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XERS | Kevin Mcculloch | President and Chief Operating Officer | Oct 1, 2026 | Sale | $9.41 | 15,000 | $141.1K | 1,599,208 | |
XERS | Kevin Mcculloch | President and Chief Operating Officer | Sep 28, 2026 | Sale | $10.00 | 25,000 | $250.0K | 1,614,208 | |
XERS | KEVIN MCCULLOCH | — | Sep 28, 2026 | Proposed Sale | $9.10 | 70,000 | $637.0K | — | |
XERS | Kevin Mcculloch | President and Chief Operating Officer | Sep 1, 2026 | Sale | $8.49 | 15,000 | $127.3K | 1,639,208 | |
XERS | Kevin Mcculloch | President and Chief Operating Officer | Aug 3, 2026 | Sale | $8.02 | 15,000 | $120.2K | 1,676,126 | |
XERS | Kevin Mcculloch | President and Chief Operating Officer | Jul 1, 2026 | Sale | $8.03 | 90,000 | $722.5K | 1,691,126 | |
XERS | KEVIN MCCULLOCH | — | Jul 1, 2026 | Proposed Sale | $7.92 | 120,000 | $950.4K | — | |
XERS | Kevin Mcculloch | President and Chief Operating Officer | Mar 12, 2026 | Option Exercise | $4.09 | 48,898 | $200.0K | 1,777,725 | |
XERS | KEVIN MCCULLOCH | — | Jan 8, 2026 | Proposed Sale | $7.21 | 60,000 | $432.6K | — |